词条 | Iranian National Formulary | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
释义 |
The Iranian National Formulary (INF) has more than 2,300 molecules registered at the Iran's Ministry of Health, including various strengths and dosage forms. The standards regarding pharmaceutical products in Iran are determined and modified by the Pharmacopeia Council. Iran has adopted a full generic-based National Drug Policy (NDP), with local production of essential drugs and vaccines as one of the main goals. [1] Formalities for approval of a new molecule can take between 1 month and 12 months (maximum), as follows:
Top 20 drug molecules and sales in Iran
See also
References1. ^https://web.archive.org/web/20070306004716/http://www.austrade.gov.au/Health-services-and-pharmaceuticals-to-Iran/default.aspx 2. ^http://iran-pharma.blogspot.com/ 1 : Health in Iran |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。